54 results
8-K
EX-1.1
TRML
Tourmaline Bio Inc
26 Jan 24
Other Events
4:12pm
at all times be effective and shall survive such termination.
Section 7. Reimbursement of Underwriters’ Expenses. If this Agreement is terminated
424B5
TRML
Tourmaline Bio Inc
26 Jan 24
Prospectus supplement for primary offering
4:08pm
product candidates, these products may become subject to unfavorable pricing regulations, reimbursement practices from third-party payors or healthcare … and reimbursement risks associated with doing business outside of the U.S.
Product liability lawsuits against us could cause us to incur substantial
424B5
TRML
Tourmaline Bio Inc
24 Jan 24
Prospectus supplement for primary offering
9:20pm
regulations, reimbursement practices from third-party payors or healthcare reform initiatives in the U.S. and abroad, which could harm our business.
We … to business, regulatory, political, operational, financial, pricing and reimbursement risks associated with doing business outside of the U.S.
Product
8-K
EX-99.1
gqxbj5 e9r4yczdqph
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.2
md7sas5y 3tjpckm
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-99.1
ocvk07c3huhd3zqw oe
8 Jan 24
Regulation FD Disclosure
9:19am
8-K
EX-10.1
mx4usti
27 Oct 23
Departure of Directors or Certain Officers
5:17pm
425
ywp6t7iprtqbu55
26 Sep 23
Business combination disclosure
8:24am
8-K
EX-99.1
c1k2q9u9rc34 luzmxu
26 Sep 23
Regulation FD Disclosure
8:21am
424B3
saa810jm
15 Sep 23
Prospectus supplement
6:31am
S-4/A
5wuigrdn nh
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
EX-10.4
9utj9op zfm1yuhoapq2
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
nt66668
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
S-4
EX-10.15
eqtg1s 8ughzl4t448dz
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm